PADI4 and hepatocellular carcinoma: Both in vivo and in vitro experiments revealed that sorafenib upregulated the expression of ARHGDIG (Rho GDP dissociation inhibitor gamma), promoted IL-4 secretion by HCC cells, activated PADI4, and induced MET formation by M2-polarized macrophages [50].